BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251

Reuters2024-12-16

Dec 16 (Reuters) - IDEAYA Biosciences Inc IDYA.O:

IDEAYA ANNOUNCES DEVELOPMENT CANDIDATE NOMINATION OF IDE251, A POTENTIAL FIRST-IN-CLASS KAT6/7 DUAL INHIBITOR TARGETING 8P11 AMPLIFICATION TUMORS IN BREAST AND LUNG CANCERS
IDEAYA BIOSCIENCES INC: TARGETING IND SUBMISSION FOR IDE251 IN 2025

Source text: ID:nPn9WYll1a

Further company coverage: IDYA.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491645667?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-16 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491645667","market":"us","top_or_hot":-1,"title":"BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251</title></head><body><p><span>Dec 16 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/IDYA\">IDEAYA Biosciences</a> Inc <span>IDYA.O</span>:</p><ul><li><p>IDEAYA ANNOUNCES DEVELOPMENT CANDIDATE NOMINATION OF IDE251, A POTENTIAL FIRST-IN-CLASS KAT6/7 DUAL INHIBITOR TARGETING 8P11 AMPLIFICATION TUMORS IN BREAST AND LUNG CANCERS</p></li><li><p>IDEAYA BIOSCIENCES INC: TARGETING IND SUBMISSION FOR IDE251 IN 2025</p></li></ul><p>Source text: <span>ID:nPn9WYll1a</span></p><p>Further company coverage: <span>IDYA.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ideaya Announces Development Candidate Nomination Of Ide251\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-16 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NE1J4:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251Dec 16 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA ANNOUNCES DEVELOPMENT CANDIDATE NOMINATION OF IDE251, A POTENTIAL FIRST-IN-...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NE1J4:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IDYA","symbol_name":"IDEAYA Biosciences","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NE1J4:1","article_id":"2491645667","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491645667","pubTimestamp":1734351046,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251Dec 16 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA ANNOUNCES DEVELOPMENT CANDIDATE NOMINATION OF IDE251, A POTENTIAL FIRST-IN-CLAS","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IDYA":"IDEAYA Biosciences","BK4139":"生物科技"},"translate_title":"简介-Ideaya宣布Ide251的开发候选提名","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDYA":0.9},"content_text":"BRIEF-Ideaya Announces Development Candidate Nomination Of Ide251Dec 16 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA ANNOUNCES DEVELOPMENT CANDIDATE NOMINATION OF IDE251, A POTENTIAL FIRST-IN-CLASS KAT6/7 DUAL INHIBITOR TARGETING 8P11 AMPLIFICATION TUMORS IN BREAST AND LUNG CANCERSIDEAYA BIOSCIENCES INC: TARGETING IND SUBMISSION FOR IDE251 IN 2025Source text: ID:nPn9WYll1aFurther company coverage: IDYA.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491645667"}